Latest period
$2.99B
YoY change
+18.4%
5Y CAGR
+11.4%
Peak year (2025)
$3.18B
Latest annual
$3.18B
Total Equity history chart for West Pharmaceutical Services (WST) from 1985 to 2025
Latest: $3.18B
Total Equity growth chart for West Pharmaceutical Services (WST) from 1985 to 2025
Latest: +18.4%
Total Equity history table for West Pharmaceutical Services (WST) from 1985 to 2025
| 2025 | $3.18B | +18.4% | +$493.70M | ||
| 2024 | $2.68B | -6.9% | −$198.70M | ||
| 2023 | $2.88B | +7.3% | +$196.10M | ||
| 2022 | $2.68B | +15.0% | +$349.50M | ||
| 2021 | $2.34B | +25.9% | +$480.90M | ||
| 2020 | $1.85B | +17.9% | +$281.30M | ||
| 2019 | $1.57B | +12.7% | +$176.90M | ||
| 2018 | $1.40B | +9.1% | +$116.40M | ||
| 2017 | $1.28B | +14.5% | +$162.40M | ||
| 2016 | $1.12B | +9.1% | +$93.60M | ||
| 2015 | $1.02B | +7.0% | +$67.00M | ||
| 2014 | $956.90M | +5.6% | +$50.50M | ||
| 2013 | $906.40M | +24.4% | +$177.50M | ||
| 2012 | $728.90M | +11.3% | +$74.00M | ||
| 2011 | $654.90M | +4.7% | +$29.20M | ||
| 2010 | $625.70M | +8.0% | +$46.60M | ||
| 2009 | $579.10M | +18.9% | +$92.00M | ||
| 2008 | $487.10M | +0.4% | +$1.80M | ||
| 2007 | $485.30M | +17.1% | +$70.80M | ||
| 2006 | $414.50M | +24.3% | +$81.00M | ||
| 2005 | $333.50M | +10.8% | +$32.40M | ||
| 2004 | $301.10M | +16.9% | +$43.50M | ||
| 2003 | $257.60M | +27.8% | +$56.10M | ||
| 2002 | $201.50M | +14.0% | +$24.70M | ||
| 2001 | $176.80M | -13.7% | −$28.00M | ||
| 2000 | $204.80M | -11.4% | −$26.40M | ||
| 1999 | $231.20M | +0.5% | +$1.10M | ||
| 1998 | $230.10M | -17.1% | −$47.60M | ||
| 1997 | $277.70M | +10.2% | +$25.70M | ||
| 1996 | $252.00M | -0.8% | −$2.10M | ||
| 1995 | $254.10M | +11.8% | +$26.80M | ||
| 1994 | $227.30M | +20.8% | +$39.20M | ||
| 1993 | $188.10M | +11.6% | +$19.50M | ||
| 1992 | $168.60M | +10.4% | +$15.90M | ||
| 1991 | $152.70M | -13.3% | −$23.40M | ||
| 1990 | $176.10M | -2.0% | −$3.60M | ||
| 1989 | $179.70M | +4.8% | +$8.30M | ||
| 1988 | $171.40M | +10.0% | +$15.60M | ||
| 1987 | $155.80M | +12.2% | +$16.90M | ||
| 1986 | $138.90M | +16.2% | +$19.40M | ||
| 1985 | $119.50M | — | — |
- 2025$3.18B+18.4%
- 2024$2.68B-6.9%
- 2023$2.88B+7.3%
- 2022$2.68B+15.0%
- 2021$2.34B+25.9%
- 2020$1.85B+17.9%
- 2019$1.57B+12.7%
- 2018$1.40B+9.1%
- 2017$1.28B+14.5%
- 2016$1.12B+9.1%
- 2015$1.02B+7.0%
- 2014$956.90M+5.6%
- 2013$906.40M+24.4%
- 2012$728.90M+11.3%
- 2011$654.90M+4.7%
- 2010$625.70M+8.0%
- 2009$579.10M+18.9%
- 2008$487.10M+0.4%
- 2007$485.30M+17.1%
- 2006$414.50M+24.3%
- 2005$333.50M+10.8%
- 2004$301.10M+16.9%
- 2003$257.60M+27.8%
- 2002$201.50M+14.0%
- 2001$176.80M-13.7%
- 2000$204.80M-11.4%
- 1999$231.20M+0.5%
- 1998$230.10M-17.1%
- 1997$277.70M+10.2%
- 1996$252.00M-0.8%
- 1995$254.10M+11.8%
- 1994$227.30M+20.8%
- 1993$188.10M+11.6%
- 1992$168.60M+10.4%
- 1991$152.70M-13.3%
- 1990$176.10M-2.0%
- 1989$179.70M+4.8%
- 1988$171.40M+10.0%
- 1987$155.80M+12.2%
- 1986$138.90M+16.2%
- 1985$119.50M—
Total Equity values are taken from West Pharmaceutical Services's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Equity at West Pharmaceutical Services (WST)
According to West Pharmaceutical Services's latest reported financial statements, the company's latest reported total equity is $2.99B. Net assets — also called stockholders' equity — equal total assets minus total liabilities. They represent the residual claim of shareholders on the company's assets and roughly track book value over time.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2025's annual total equity for West Pharmaceutical Services (WST) came in at $3.18B – grew 18.4% year-over-year.
Over 2020–2025 (5 years), West Pharmaceutical Services total equity expanded at a +11.4% compound annual rate, with mixed annual results across the window.
The highest annual total equity of $3.18B was reported in 2025. The lowest in the available history was $119.50M in 1985.
West Pharmaceutical Services Total Equity by Year
West Pharmaceutical Services Total Equity 2025: $3.18B
In 2025, West Pharmaceutical Services reported total equity of $3.18B, grew 18.4% from 2024. This figure represents the highest annual value in the available history.
West Pharmaceutical Services Total Equity 2024: $2.68B
West Pharmaceutical Services total equity in 2024 was $2.68B, declined 6.9% below 2023.
West Pharmaceutical Services Total Equity 2023: $2.88B
2023's total equity for West Pharmaceutical Services came in at $2.88B, grew 7.3% from 2022.
West Pharmaceutical Services Total Equity 2022: $2.68B
West Pharmaceutical Services posted total equity of $2.68B in 2022, grew 15.0% from 2021.
West Pharmaceutical Services Total Equity 2021: $2.34B
West Pharmaceutical Services total equity in 2021 was $2.34B.
See more financial history for West Pharmaceutical Services (WST).
Sector peers by Total Equity
Healthcare peers of West Pharmaceutical Services (WST), ranked by their latest total equity
| $94.11B | |
| $81.54B | |
| $52.61B | |
| $48.67B | |
| $30.52B | |
| $26.54B | |
| $8.66B | |
| −$3.27B |
- $94.11B
- $81.54B
- $52.61B
- $48.67B
- $30.52B
- $26.54B
- $8.66B
- −$3.27B
Frequently asked questions
West Pharmaceutical Services (WST) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation